The Intestinal Microbiota in Colorectal Cancer

Cancer Cell

Volumn 33, Issue 6, 2018, Pages 954-964

  Tilg, Herbert ^a   Adolph, Timon E ^a   Gerner, Romana R ^a   Moschen, Alexander R ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

bacteria; cancer; immunity; inflammation; microbiota

Indexed keywords

CYTOKINE; INFLAMMASOME; PATTERN RECOGNITION RECEPTOR;

BACTERIAL STRAIN; BACTEROIDES FRAGILIS; BIOFILM; CARCINOGENESIS; COLORECTAL CANCER; DISEASE ASSOCIATION; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; HUMAN; INTESTINE FLORA; METAGENOMICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR PROMOTION; ANIMAL; BIOLOGICAL MODEL; CELL TRANSFORMATION; COLON; COLORECTAL TUMOR; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RECTUM;

ANIMALS; CARCINOGENESIS; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLORECTAL NEOPLASMS; GASTROINTESTINAL MICROBIOME; HUMANS; MODELS, BIOLOGICAL; RECTUM; SIGNAL TRANSDUCTION;

EID: 85044161418     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2018.03.004     Document Type: Review

References (119)

1. Agus, A., Denizot, J., Thevenot, J., Martinez-Medina, M., Massier, S., Sauvanet, P., Bernalier-Donadille, A., Denis, S., Hofman, P., Bonnet, R., et al. Western diet induces a shift in microbiota composition enhancing susceptibility to adherent-invasive E. coli infection and intestinal inflammation. Sci. Rep., 6, 2016, 19032.
2. Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., Goedert, J.J., Hayes, R.B., Yang, L., Human gut microbiome and risk for colorectal cancer. J. Natl. Cancer Inst. 105 (2013), 1907–1911.
3. Arnold, M., Sierra, M.S., Laversanne, M., Soerjomataram, I., Jemal, A., Bray, F., Global patterns and trends in colorectal cancer incidence and mortality. Gut 66 (2017), 683–691.
4. Arthur, J.C., Gharaibeh, R.Z., Muhlbauer, M., Perez-Chanona, E., Uronis, J.M., McCafferty, J., Fodor, A.A., Jobin, C., Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer. Nat. Commun., 5, 2014, 4724.
5. Arthur, J.C., Gharaibeh, R.Z., Uronis, J.M., Perez-Chanona, E., Sha, W., Tomkovich, S., Muhlbauer, M., Fodor, A.A., Jobin, C., VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci. Rep., 3, 2013, 2868.
6. Arthur, J.C., Perez-Chanona, E., Muhlbauer, M., Tomkovich, S., Uronis, J.M., Fan, T.J., Campbell, B.J., Abujamel, T., Dogan, B., Rogers, A.B., et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338 (2012), 120–123.
7. Belcheva, A., Irrazabal, T., Robertson, S.J., Streutker, C., Maughan, H., Rubino, S., Moriyama, E.H., Copeland, J.K., Kumar, S., Green, B., et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 158 (2014), 288–299.
8. Boleij, A., Hechenbleikner, E.M., Goodwin, A.C., Badani, R., Stein, E.M., Lazarev, M.G., Ellis, B., Carroll, K.C., Albesiano, E., Wick, E.C., et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60 (2015), 208–215.
9. Bonnet, M., Buc, E., Sauvanet, P., Darcha, C., Dubois, D., Pereira, B., Dechelotte, P., Bonnet, R., Pezet, D., Darfeuille-Michaud, A., Colonization of the human gut by E. coli and colorectal cancer risk. Clin. Cancer Res. 20 (2014), 859–867.
10. Brennan, C.A., Garrett, W.S., Gut microbiota, inflammation, and colorectal cancer. Annu. Rev. Microbiol. 70 (2016), 395–411.
11. Bullman, S., Pedamallu, C.S., Sicinska, E., Clancy, T.E., Zhang, X., Cai, D., Neuberg, D., Huang, K., Guevara, F., Nelson, T., et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358 (2017), 1443–1448.
12. Cao, Y., Wu, K., Mehta, R., Drew, D.A., Song, M., Lochhead, P., Nguyen, L.H., Izard, J., Fuchs, C.S., Garrett, W.S., et al. Long-term use of antibiotics and risk of colorectal adenoma. Gut, 2017, 10.1136/gutjnl-2016-313413.
13. Castellarin, M., Warren, R.L., Freeman, J.D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R.A., Holt, R.A., Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22 (2012), 299–306.
14. Charbonneau, M.R., Blanton, L.V., DiGiulio, D.B., Relman, D.A., Lebrilla, C.B., Mills, D.A., Gordon, J.I., A microbial perspective of human developmental biology. Nature 535 (2016), 48–55.
15. Chassaing, B., Koren, O., Goodrich, J.K., Poole, A.C., Srinivasan, S., Ley, R.E., Gewirtz, A.T., Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519 (2015), 92–96.
16. Chen, G.Y., Shaw, M.H., Redondo, G., Nunez, G., The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res. 68 (2008), 10060–10067.
17. Choi, C.R., Bakir, I.A., Hart, A.L., Graham, T.A., Clonal evolution of colorectal cancer in IBD. Nat. Rev. Gastroenterol. Hepatol. 14 (2017), 218–229.
18. Collins, D., Hogan, A.M., Winter, D.C., Microbial and viral pathogens in colorectal cancer. Lancet Oncol. 12 (2011), 504–512.
19. Cougnoux, A., Dalmasso, G., Martinez, R., Buc, E., Delmas, J., Gibold, L., Sauvanet, P., Darcha, C., Dechelotte, P., Bonnet, M., et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut 63 (2014), 1932–1942.
20. Cougnoux, A., Delmas, J., Gibold, L., Fais, T., Romagnoli, C., Robin, F., Cuevas-Ramos, G., Oswald, E., Darfeuille-Michaud, A., Prati, F., et al. Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria. Gut 65 (2016), 278–285.
21. Couturier-Maillard, A., Secher, T., Rehman, A., Normand, S., De Arcangelis, A., Haesler, R., Huot, L., Grandjean, T., Bressenot, A., Delanoye-Crespin, A., et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 123 (2013), 700–711.
22. Cuevas-Ramos, G., Petit, C.R., Marcq, I., Boury, M., Oswald, E., Nougayrede, J.P., Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl. Acad. Sci. USA 107 (2010), 11537–11542.
23. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
24. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J.B., Massart, S., Collini, S., Pieraccini, G., Lionetti, P., Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA 107 (2010), 14691–14696.
25. Dejea, C.M., Sears, C.L., Do biofilms confer a pro-carcinogenic state?. Gut Microbes 7 (2016), 54–57.
26. Dejea, C.M., Wick, E.C., Hechenbleikner, E.M., White, J.R., Mark Welch, J.L., Rossetti, B.J., Peterson, S.N., Snesrud, E.C., Borisy, G.G., Lazarev, M., et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc. Natl. Acad. Sci. USA 111 (2014), 18321–18326.
27. Dejea, C.M., Fathi, P., Craig, J.M., Boleij, A., Taddese, R., Geis, A.L., Wu, X., DeStefano Shields, C.E., Hechenbleikner, E.M., Huso, D.L., et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359 (2018), 592–597.
28. Denizot, J., Desrichard, A., Agus, A., Uhrhammer, N., Dreux, N., Vouret-Craviari, V., Hofman, P., Darfeuille-Michaud, A., Barnich, N., Diet-induced hypoxia responsive element demethylation increases CEACAM6 expression, favouring Crohn's disease-associated Escherichia coli colonisation. Gut 64 (2015), 428–437.
29. Dennis, K.L., Wang, Y., Blatner, N.R., Wang, S., Saadalla, A., Trudeau, E., Roers, A., Weaver, C.T., Lee, J.J., Gilbert, J.A., et al. Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells. Cancer Res. 73 (2013), 5905–5913.
30. Desai, M.S., Seekatz, A.M., Koropatkin, N.M., Kamada, N., Hickey, C.A., Wolter, M., Pudlo, N.A., Kitamoto, S., Terrapon, N., Muller, A., et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167 (2016), 1339–1353.e21.
31. DeStefano Shields, C.E., Van Meerbeke, S.W., Housseau, F., Wang, H., Huso, D.L., Casero, R.A. Jr., O'Hagan, H.M., Sears, C.L., Reduction of murine colon tumorigenesis driven by enterotoxigenic Bacteroides fragilis using cefoxitin treatment. J. Infect. Dis. 214 (2016), 122–129.
32. Devkota, S., Wang, Y., Musch, M.W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D.A., Jabri, B., Chang, E.B., Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10–/– mice. Nature 487 (2012), 104–108.
33. Drewes, J.L., Housseau, F., Sears, C.L., Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy. Br. J. Cancer 115 (2016), 273–280.
34. Drewes, J.L., White, J.R., Dejea, C.M., Fathi, P., Iyadorai, T., Vadivelu, J., Roslani, A.C., Wick, E.C., Mongodin, E.F., Loke, M.F., et al. High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia. NPJ Biofilms Microbiomes, 3, 2017, 34.
35. Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M.J., Valles-Colomer, M., Vandeputte, D., et al. Population-level analysis of gut microbiome variation. Science 352 (2016), 560–564.
36. Feng, Q., Liang, S., Jia, H., Stadlmayr, A., Tang, L., Lan, Z., Zhang, D., Xia, H., Xu, X., Jie, Z., et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat. Commun., 6, 2015, 6528.
37. Flanagan, L., Schmid, J., Ebert, M., Soucek, P., Kunicka, T., Liska, V., Bruha, J., Neary, P., Dezeeuw, N., Tommasino, M., et al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur. J. Clin. Microbiol. Infect. Dis. 33 (2014), 1381–1390.
38. Flemer, B., Warren, R.D., Barrett, M.P., Cisek, K., Das, A., Jeffery, I.B., Hurley, E., O'Riordain, M., Shanahan, F., O'Toole, P.W., The oral microbiota in colorectal cancer is distinctive and predictive. Gut, 2017, 10.1136/gutjnl-2017-314814.
39. Geller, L.T., Barzily-Rokni, M., Danino, T., Jonas, O.H., Shental, N., Nejman, D., Gavert, N., Zwang, Y., Cooper, Z.A., Shee, K., et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357 (2017), 1156–1160.
40. Gensollen, T., Iyer, S.S., Kasper, D.L., Blumberg, R.S., How colonization by microbiota in early life shapes the immune system. Science 352 (2016), 539–544.
41. Gevers, D., Kugathasan, S., Denson, L.A., Vazquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S.J., Yassour, M., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15 (2014), 382–392.
42. Goodwin, A.C., Destefano Shields, C.E., Wu, S., Huso, D.L., Wu, X., Murray-Stewart, T.R., Hacker-Prietz, A., Rabizadeh, S., Woster, P.M., Sears, C.L., Casero, R.A. Jr., Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc. Natl. Acad. Sci. USA 108 (2011), 15354–15359.
43. Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V., Prieto, P.A., Vicente, D., Hoffman, K., Wei, S.C., et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359 (2018), 97–103.
44. Guinney, J., Dienstmann, R., Wang, X., de Reynies, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. The consensus molecular subtypes of colorectal cancer. Nat. Med. 21 (2015), 1350–1356.
45. Gur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42 (2015), 344–355.
46. Halfvarson, J., Brislawn, C.J., Lamendella, R., Vazquez-Baeza, Y., Walters, W.A., Bramer, L.M., D'Amato, M., Bonfiglio, F., McDonald, D., Gonzalez, A., et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat. Microbiol., 2, 2017, 17004.
47. Housseau, F., Wu, S., Wick, E.C., Fan, H., Wu, X., Llosa, N.J., Smith, K.N., Tam, A., Ganguly, S., Wanyiri, J.W., et al. Redundant innate and adaptive sources of IL17 production drive colon tumorigenesis. Cancer Res. 76 (2016), 2115–2124.
48. Hu, B., Elinav, E., Huber, S., Strowig, T., Hao, L., Hafemann, A., Jin, C., Wunderlich, C., Wunderlich, T., Eisenbarth, S.C., Flavell, R.A., Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc. Natl. Acad. Sci. USA 110 (2013), 9862–9867.
49. Hu, Y., Le Leu, R.K., Christophersen, C.T., Somashekar, R., Conlon, M.A., Meng, X.Q., Winter, J.M., Woodman, R.J., McKinnon, R., Young, G.P., Manipulation of the gut microbiota using resistant starch is associated with protection against colitis-associated colorectal cancer in rats. Carcinogenesis 37 (2016), 366–375.
50. Ijssennagger, N., Belzer, C., Hooiveld, G.J., Dekker, J., van Mil, S.W., Muller, M., Kleerebezem, M., van der Meer, R., Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc. Natl. Acad. Sci. USA 112 (2015), 10038–10043.
51. Ito, M., Kanno, S., Nosho, K., Sukawa, Y., Mitsuhashi, K., Kurihara, H., Igarashi, H., Takahashi, T., Tachibana, M., Takahashi, H., et al. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Int. J. Cancer 137 (2015), 1258–1268.
52. Johnson, C.H., Dejea, C.M., Edler, D., Hoang, L.T., Santidrian, A.F., Felding, B.H., Ivanisevic, J., Cho, K., Wick, E.C., Hechenbleikner, E.M., et al. Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab. 21 (2015), 891–897.
53. Kang, M., Martin, A., Microbiome and colorectal cancer: unraveling host-microbiota interactions in colitis-associated colorectal cancer development. Semin. Immunol. 32 (2017), 3–13.
54. Kesselring, R., Glaesner, J., Hiergeist, A., Naschberger, E., Neumann, H., Brunner, S.M., Wege, A.K., Seebauer, C., Kohl, G., Merkl, S., et al. IRAK-M expression in tumor cells supports colorectal cancer progression through reduction of antimicrobial defense and stabilization of STAT3. Cancer Cell 29 (2016), 684–696.
55. Khazaie, K., Zadeh, M., Khan, M.W., Bere, P., Gounari, F., Dennis, K., Blatner, N.R., Owen, J.L., Klaenhammer, T.R., Mohamadzadeh, M., Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl. Acad. Sci. USA 109 (2012), 10462–10467.
56. Kostic, A.D., Chun, E., Robertson, L., Glickman, J.N., Gallini, C.A., Michaud, M., Clancy, T.E., Chung, D.C., Lochhead, P., Hold, G.L., et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14 (2013), 207–215.
57. Kostic, A.D., Gevers, D., Pedamallu, C.S., Michaud, M., Duke, F., Earl, A.M., Ojesina, A.I., Jung, J., Bass, A.J., Tabernero, J., et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22 (2012), 292–298.
58. Kyrgiou, M., Kalliala, I., Markozannes, G., Gunter, M.J., Paraskevaidis, E., Gabra, H., Martin-Hirsch, P., Tsilidis, K.K., Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ, 356, 2017, j477.
59. Lasry, A., Zinger, A., Ben-Neriah, Y., Inflammatory networks underlying colorectal cancer. Nat. Immunol. 17 (2016), 230–240.
60. Levy, J., Cacheux, W., Bara, M.A., L'Hermitte, A., Lepage, P., Fraudeau, M., Trentesaux, C., Lemarchand, J., Durand, A., Crain, A.M., et al. Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth. Nat. Cell Biol. 17 (2015), 1062–1073.
61. Liang, Q., Chiu, J., Chen, Y., Huang, Y., Higashimori, A., Fang, J., Brim, H., Ashktorab, H., Ng, S.C., Ng, S.S.M., et al. Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer. Clin. Cancer Res. 23 (2017), 2061–2070.
62. Louis, P., Hold, G.L., Flint, H.J., The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12 (2014), 661–672.
63. Luddy, K.A., Robertson-Tessi, M., Tafreshi, N.K., Soliman, H., Morse, D.L., The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition. Front. Immunol., 5, 2014, 429.
64. Lynch, S.V., Pedersen, O., The human intestinal microbiome in health and disease. N. Engl. J. Med. 375 (2016), 2369–2379.
65. Malik, A., Sharma, D., Zhu, Q., Karki, R., Guy, C.S., Vogel, P., Kanneganti, T.D., IL-33 regulates the IgA-microbiota axis to restrain IL-1alpha-dependent colitis and tumorigenesis. J. Clin. Invest. 126 (2016), 4469–4481.
66. Man, S.M., Zhu, Q., Zhu, L., Liu, Z., Karki, R., Malik, A., Sharma, D., Li, L., Malireddi, R.K., Gurung, P., et al. Critical role for the DNA sensor AIM2 in stem cell proliferation and cancer. Cell 162 (2015), 45–58.
67. Mantovani, A., Allavena, P., Sica, A., Balkwill, F., Cancer-related inflammation. Nature 454 (2008), 436–444.
68. Marchesi, J.R., Adams, D.H., Fava, F., Hermes, G.D., Hirschfield, G.M., Hold, G., Quraishi, M.N., Kinross, J., Smidt, H., Tuohy, K.M., et al. The gut microbiota and host health: a new clinical frontier. Gut 65 (2016), 330–339.
69. Mehta, R.S., Nishihara, R., Cao, Y., Song, M., Mima, K., Qian, Z.R., Nowak, J.A., Kosumi, K., Hamada, T., Masugi, Y., et al. Association of dietary patterns with risk of colorectal cancer subtypes classified by Fusobacterium nucleatum in tumor tissue. JAMA Oncol. 3 (2017), 921–927.
70. Mima, K., Cao, Y., Chan, A.T., Qian, Z.R., Nowak, J.A., Masugi, Y., Shi, Y., Song, M., da Silva, A., Gu, M., et al. Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location. Clin. Transl. Gastroenterol., 7, 2016, e200.
71. Mima, K., Nishihara, R., Qian, Z.R., Cao, Y., Sukawa, Y., Nowak, J.A., Yang, J., Dou, R., Masugi, Y., Song, M., et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 65 (2016), 1973–1980.
72. Mima, K., Sukawa, Y., Nishihara, R., Qian, Z.R., Yamauchi, M., Inamura, K., Kim, S.A., Masuda, A., Nowak, J.A., Nosho, K., et al. Fusobacterium nucleatum and T cells in colorectal carcinoma. JAMA Oncol. 1 (2015), 653–661.
73. Momen-Heravi, F., Babic, A., Tworoger, S.S., Zhang, L., Wu, K., Smith-Warner, S.A., Ogino, S., Chan, A.T., Meyerhardt, J., Giovannucci, E., et al. Periodontal disease, tooth loss and colorectal cancer risk: results from the Nurses’ Health Study. Int. J. Cancer 140 (2017), 646–652.
74. Moschen, A.R., Gerner, R.R., Wang, J., Klepsch, V., Adolph, T.E., Reider, S.J., Hackl, H., Pfister, A., Schilling, J., Moser, P.L., et al. Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations. Cell Host Microbe 19 (2016), 455–469.
75. Nakatsu, G., Li, X., Zhou, H., Sheng, J., Wong, S.H., Wu, W.K., Ng, S.C., Tsoi, H., Dong, Y., Zhang, N., et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat. Commun., 6, 2015, 8727.
76. Nosho, K., Sukawa, Y., Adachi, Y., Ito, M., Mitsuhashi, K., Kurihara, H., Kanno, S., Yamamoto, I., Ishigami, K., Igarashi, H., et al. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. World J. Gastroenterol. 22 (2016), 557–566.
77. O'Keefe, S.J., Diet, microorganisms and their metabolites, and colon cancer. Nat. Rev. Gastroenterol. Hepatol. 13 (2016), 691–706.
78. O'Keefe, S.J., Li, J.V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Posma, J.M., Kinross, J., Wahl, E., Ruder, E., et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat. Commun., 6, 2015, 6342.
79. O'Toole, P.W., Marchesi, J.R., Hill, C., Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol., 2, 2017, 17057.
80. Ohkusa, T., Okayasu, I., Ogihara, T., Morita, K., Ogawa, M., Sato, N., Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 52 (2003), 79–83.
81. Pascal, V., Pozuelo, M., Borruel, N., Casellas, F., Campos, D., Santiago, A., Martinez, X., Varela, E., Sarrabayrouse, G., Machiels, K., et al. A microbial signature for Crohn's disease. Gut 66 (2017), 813–822.
82. Peuker, K., Muff, S., Wang, J., Kunzel, S., Bosse, E., Zeissig, Y., Luzzi, G., Basic, M., Strigli, A., Ulbricht, A., et al. Epithelial calcineurin controls microbiota-dependent intestinal tumor development. Nat. Med. 22 (2016), 506–515.
83. Routy, B., Le Chatelier, E., Derosa, L., Duong, C.P.M., Alou, M.T., Daillere, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M.P., et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359 (2018), 91–97.
84. Roy, S., Trinchieri, G., Microbiota: a key orchestrator of cancer therapy. Nat. Rev. Cancer 17 (2017), 271–285.
85. Rubinstein, M.R., Wang, X., Liu, W., Hao, Y., Cai, G., Han, Y.W., Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14 (2013), 195–206.
86. Rutkowski, M.R., Stephen, T.L., Svoronos, N., Allegrezza, M.J., Tesone, A.J., Perales-Puchalt, A., Brencicova, E., Escovar-Fadul, X., Nguyen, J.M., Cadungog, M.G., et al. Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation. Cancer Cell 27 (2015), 27–40.
87. Schnorr, S.L., Candela, M., Rampelli, S., Centanni, M., Consolandi, C., Basaglia, G., Turroni, S., Biagi, E., Peano, C., Severgnini, M., et al. Gut microbiome of the Hadza hunter-gatherers. Nat. Commun., 5, 2014, 3654.
88. Sears, C.L., Garrett, W.S., Microbes, microbiota, and colon cancer. Cell Host Microbe 15 (2014), 317–328.
89. Sears, C.L., Geis, A.L., Housseau, F., Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. J. Clin. Invest. 124 (2014), 4166–4172.
90. Sender, R., Fuchs, S., Milo, R., Revised estimates for the number of human and bacteria cells in the body. PLoS Biol., 14, 2016, e1002533.
91. Shah, M.S., DeSantis, T.Z., Weinmaier, T., McMurdie, P.J., Cope, J.L., Altrichter, A., Yamal, J.M., Hollister, E.B., Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer. Gut, 2017, 10.1136/gutjnl-2016-313189.
92. Shanahan, F., van Sinderen, D., O'Toole, P.W., Stanton, C., Feeding the microbiota: transducer of nutrient signals for the host. Gut, 2017, 10.1136/gutjnl-2017-313872.
93. Siegel, R.L., Fedewa, S.A., Anderson, W.F., Miller, K.D., Ma, J., Rosenberg, P.S., Jemal, A., Colorectal cancer incidence patterns in the United States, 1974–2013. J. Natl. Cancer Inst., 109, 2017, 10.1093/jnci/djw322.
94. Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P.D., Manicassamy, S., Munn, D.H., et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40 (2014), 128–139.
95. Song, M., Garrett, W.S., Chan, A.T., Nutrients, foods, and colorectal cancer prevention. Gastroenterology 148 (2015), 1244–1260.e16.
96. Sonnenburg, E.D., Smits, S.A., Tikhonov, M., Higginbottom, S.K., Wingreen, N.S., Sonnenburg, J.L., Diet-induced extinctions in the gut microbiota compound over generations. Nature 529 (2016), 212–215.
97. Sonnenburg, J.L., Backhed, F., Diet-microbiota interactions as moderators of human metabolism. Nature 535 (2016), 56–64.
98. Sun, T., Liu, S., Zhou, Y., Yao, Z., Zhang, D., Cao, S., Wei, Z., Tan, B., Li, Y., Lian, Z., Wang, S., Evolutionary biologic changes of gut microbiota in an ‘adenoma-carcinoma sequence’ mouse colorectal cancer model induced by 1, 2-dimethylhydrazine. Oncotarget 8 (2017), 444–457.
99. Tilg, H., Kaser, A., Gut microbiome, obesity, and metabolic dysfunction. J. Clin. Invest. 121 (2011), 2126–2132.
100. Tlaskalova-Hogenova, H., Vannucci, L., Klimesova, K., Stepankova, R., Krizan, J., Kverka, M., Microbiome and colorectal carcinoma: insights from germ-free and conventional animal models. Cancer J. 20 (2014), 217–224.
101. Tomkovich, S., Yang, Y., Winglee, K., Gauthier, J., Muhlbauer, M., Sun, X., Mohamadzadeh, M., Liu, X., Martin, P., Wang, G.P., et al. Locoregional effects of microbiota in a preclinical model of colon carcinogenesis. Cancer Res. 77 (2017), 2620–2632.
102. Tsoi, H., Chu, E.S.H., Zhang, X., Sheng, J., Nakatsu, G., Ng, S.C., Chan, A.W.H., Chan, F.K.L., Sung, J.J.Y., Yu, J., Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice. Gastroenterology 152 (2017), 1419–1433.e5.
103. Uronis, J.M., Muhlbauer, M., Herfarth, H.H., Rubinas, T.C., Jones, G.S., Jobin, C., Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One, 4, 2009, e6026.
104. Vandeputte, D., Falony, G., Vieira-Silva, S., Tito, R.Y., Joossens, M., Raes, J., Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65 (2016), 57–62.
105. Veziant, J., Gagniere, J., Jouberton, E., Bonnin, V., Sauvanet, P., Pezet, D., Barnich, N., Miot-Noirault, E., Bonnet, M., Association of colorectal cancer with pathogenic Escherichia coli: focus on mechanisms using optical imaging. World J. Clin. Oncol. 7 (2016), 293–301.
106. Viennois, E., Merlin, D., Gewirtz, A.T., Chassaing, B., Dietary emulsifier-induced low-grade inflammation promotes colon carcinogenesis. Cancer Res. 77 (2017), 27–40.
107. Viljoen, K.S., Dakshinamurthy, A., Goldberg, P., Blackburn, J.M., Quantitative profiling of colorectal cancer-associated bacteria reveals associations between Fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PLoS One, 10, 2015, e0119462.
108. Vital, M., Howe, A.C., Tiedje, J.M., Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. MBio, 5, 2014, e00889.
109. Watt, E., Gemmell, M.R., Berry, S., Glaire, M., Farquharson, F., Louis, P., Murray, G.I., El-Omar, E., Hold, G.L., Extending colonic mucosal microbiome analysis-assessment of colonic lavage as a proxy for endoscopic colonic biopsies. Microbiome, 4, 2016, 61.
110. West, N.R., McCuaig, S., Franchini, F., Powrie, F., Emerging cytokine networks in colorectal cancer. Nat. Rev. Immunol. 15 (2015), 615–629.
111. Wong, S.H., Zhao, L., Zhang, X., Nakatsu, G., Han, J., Xu, W., Xiao, X., Kwong, T.N., Tsoi, H., Wu, W.K., et al. Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology 153 (2017), 1621–1633.e6.
112. Wu, S., Rhee, K.J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.R., Huso, D.L., Brancati, F.L., Wick, E., McAllister, F., et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15 (2009), 1016–1022.
113. Yang, Y., Weng, W., Peng, J., Hong, L., Yang, L., Toiyama, Y., Gao, R., Liu, M., Yin, M., Pan, C., et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-kappaB, and up-regulating expression of microRNA-21. Gastroenterology 152 (2017), 851–866.e24.
114. Yazici, C., Wolf, P.G., Kim, H., Cross, T.L., Vermillion, K., Carroll, T., Augustus, G.J., Mutlu, E., Tussing-Humphreys, L., Braunschweig, C., et al. Race-dependent association of sulfidogenic bacteria with colorectal cancer. Gut 66 (2017), 1983–1994.
115. Yu, J., Feng, Q., Wong, S.H., Zhang, D., Liang, Q.Y., Qin, Y., Tang, L., Zhao, H., Stenvang, J., Li, Y., et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66 (2017), 70–78.
116. Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170 (2017), 548–563.e16.
117. Yu, Y.N., Yu, T.C., Zhao, H.J., Sun, T.T., Chen, H.M., Chen, H.Y., An, H.F., Weng, Y.R., Yu, J., Li, M., et al. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Oncotarget 6 (2015), 32013–32026.
118. Zhou, Y.J., Zhao, D.D., Liu, H., Chen, H.T., Li, J.J., Mu, X.Q., Liu, Z., Li, X., Tang, L., Zhao, Z.Y., et al. Cancer killers in the human gut microbiota: diverse phylogeny and broad spectra. Oncotarget 8 (2017), 49574–49591.
119. Zmora, N., Levy, M., Pevsner-Fishcer, M., Elinav, E., Inflammasomes and intestinal inflammation. Mucosal. Immunol. 10 (2017), 865–883.